Managed care

Article Abstract:

A survey conducted by KPMG Peat Marwick indicates that health insurance premiums registered an increase of only 3.3% in 1998. Even amid the proposition that prescription drug prices may be stimulating health cost inflation, the result of the latest survey involving 1,600 US employees, represents the fourth consecutive year that premiums have risen by less than the average increase in workesr' earnings, which was quoted at 3.7% in 1998. The survey also reveals that some employers are eliminating preexisting condition clauses on account of provisions in the 1996 insurance portability law, which restricts the number of employees whose care can be put on hold for such justifications.

Comment:

Survey indicates that health insurance premiums registered an increase of only 3.3% in 1998

Research Findings, Commodity & service prices, Industry Market Data, Marketing/Advertising Methods, Direct Health and Medical Insurance Carriers, Medical Care Insurance, Psychographics, Health insurance, Article

---

UNHAPPY LANDINGS

Article Abstract:

Impact of the balanced budget adopted by the government in 1997 upon the United States health care system is discussed in this article. According to the author, rural hospitals and home health agencies are the biggest losers in the light of the federal policies.

Health Care, Health Care and Social Assistance, Statistical Data Included, Health care industry, Medical care, Economic policy, United States. Congress. House

---

Similar abstracts:

• Abstracts: Madonna slept here. John E. Abele. If you want to play you've got to pay; community outreach is the name of the game, but how do hospitals pay for it?
• Abstracts: Painful realities. Cuba care. Russian rehab: enterprising Westerners have imported managed care and one-stop clinics. That's pricey treatment for a tattered health system
• Abstracts: When age becomes ageless. Consumers. The long reach of bugs without borders
• Abstracts: Bigger sales forces for smaller companies. After Redux? Here's how Meridia was introduced into a "tainted" market
• Abstracts: FDA asks court to limit scope of ruling on off-label drug info; WLF finds no basis for action. Cholestin case could change marketing

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.